Novartis India Share Price in 2010: Chart, Monthly Trends, & Analysis

How did Novartis India shares perform in 2010?

Let's find out!

Novartis India share price in 2010 was ₹654 Its price on 1st January 2010 was ₹560, and by 31st December 2010 it moved to ₹654, giving a positive return of 16.78% for the year.

Novartis India Share Open, High, Low, and Close prices for the Year 2010 are as follows:

Open	High	Low	Close
₹560	₹735	₹511	₹654
1st Jan 2010	Occured in Nov 2010	Occured in Feb 2010	31st Dec 2010

This page will help you understand how Novartis India performed in 2010. Let's get started.

For complete insights into Novartis India’s incredible stock price performance and growth, see: Novartis India Historical Share Price Data from its IPO to 2025

Table: Novartis India Share Monthly Close, Low, High Prices for 2010

Month	Novartis India	Change%	↑High - ↓Low
Jan	₹525.25	-	↑ ₹600 ↓ ₹512.04
Feb	₹520.1	-1%	↑ ₹544.75 ↓ ₹511
Mar	₹573.2	10.2%	↑ ₹600 ↓ ₹518.5
Apr	₹595.25	3.8%	↑ ₹633 ↓ ₹546.04
May	₹597.7	0.4%	↑ ₹632.5 ↓ ₹545
Jun	₹664.2	11.1%	↑ ₹689 ↓ ₹590
Jul	₹650.04	-2.2%	↑ ₹699.4 ↓ ₹608
Aug	₹652.95	0.4%	↑ ₹680.05 ↓ ₹608.04
Sep	₹628.1	-3.9%	↑ ₹667 ↓ ₹600
Oct	₹661.8	5.3%	↑ ₹693 ↓ ₹611.29
Nov	₹644.15	-2.7%	↑ ₹735 ↓ ₹603
Dec	₹654	1.5%	↑ ₹674.95 ↓ ₹620.1

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Novartis India in 2010?

In 2010, the opening price of Novartis India share was ₹560.00. Today, the price stands at ₹672.25, reflecting a growth of 20.04%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2010 would have become ₹12,004.46 by 2025. This represents a CAGR of 1.23%.

---

You might also like to check: Novartis India Stock Price in 2009 or Novartis India Stock Price in 2011

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.